Catalog Advanced Search
149 Results
-
Includes a Live Web Event on 09/14/2023 at 11:00 AM (PDT)
Live webinar about the nurse’s role and responsibility in AMR and AMS
Description:
Date: September 14, 2023
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
A multidisciplinary approach is needed to implement an effective antimicrobial stewardship (AMS) program. Traditionally, nurses have been excluded from the AMS team structure. However, to steer a successful program in the increasingly complex field of health care, it is crucial to involve dedicated nurses and nursing professionals. The role of nurses in caring for and improving outcomes for patients with infections and sepsis is well known. Nurses can also directly impact antimicrobial resistance (AMR) and antimicrobial stewardship (AMS) through a variety of nurse-driven protocols and practices. These can include assessments and allergy documentation, evidence-based specimen collection techniques, consideration for antimicrobial duration and route of administration, and thoughtfulness in culturing. In this presentation, attendees will learn about the nurse’s role and responsibility in AMR and AMS, gain an understanding of opportunities for and barriers to nurses’ engagement in AMS across the continuum of care, and examine key strategies to empower nurses’ ownership, accountability, and contribution to the core elements of AMS.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporter:
Sepsis Alliance gratefully acknowledges the support provided for this webinar by Roche.
May M. Riley, MSN, MPH, RN, ACNP, CCRN, CIC, FAPIC
Infection Control Consultant
Stanford Health Care
May Riley, MSN, MPH, RN,ACNP, CCRN, CIC, FAPIC is an Infection Control Consultant at Stanford Health Care. May has been practicing in the field of infection control and hospital epidemiology since 2005. She has extensive nursing experience including medical/surgical, neurosurgery, trauma, liver transplant, and critical care nursing. May holds two master degrees, an MSN from the UCLA School of Nursing in acute care, and an MPH in Epidemiology from the UCLA School of Public Health. She will start her doctor of nursing practice study in August.
May has numerous publications on infection prevention and infectious disease control. May served on the ANA/CDC Work Group for Engaging Nurses in Antibiotic Stewardship as a subject matter expert to contribute her expertise in developing the ANA/CDC White Paper defining the nurse’s role in stewardship. Additionally, May collaborated with APIC to conduct a leadership interview. She interviewed the founders and pioneers in the ANA/CDC Work Group for Engaging Nurses in Antibiotic Stewardship. To trumpet the vision and mission of engaging nurses to antibiotic stewardship, May published the leadership interview article in one of the APIC flagship journals ̶ Prevention Strategist in 2016.
May is also a Consulting Editor for Journal of “Critical Care Nursing Clinics of North America” in Elsevier. -
Includes a Live Web Event on 07/18/2023 at 11:00 AM (PDT)
Content determined by Wolters Kluwer (no CE credits)
Description:
Date: July 18, 2023
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
Sepsis is already the most expensive hospital condition. With CMS proposing to adopt SEP-1 into its Hospital Value-Based Purchasing (VBP) Program beginning in the FY 2026 program year, the potential impact is even greater. As key sepsis program team members, you know it is challenging to move the needle and drive sustainable improvements. Sepsis is a complex, multi-step process, and nationally the average SEP-1 bundle compliance is only 50%. With VBP adoption on the horizon, it is essential to move quickly to position yourself to take advantage of the coming changes. So how do you convince your organization's leadership team that you need additional investment and resources to support your sepsis program?
Learning Objectives:
At the end of the activity, the learner should be able to:
- Explain the implications of CMS adding SEP-1 quality measure to its VBP program;
- Discuss a strategy to achieve and sustain SEP-1 compliance, including overcoming key challenges in patient identification, timely SEP-1 care delivery, and proactive management;
- Implement best practices to engage a leadership team to champion and invest in the tools, people, and processes required to meet sepsis performance goals.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporter:
Sepsis Alliance gratefully acknowledges the support for this webinar by Wolters Kluwer.
Itay Klaz, MD, MHCI
Medical Director
Wolters Kluwer
Itay Klaz, MD, MHCI, is responsible for directing clinical efforts toward the development, implementation, and support of the Wolters Kluwer suite of surveillance software solutions, primarily focusing on Wolters Kluwer POC Advisor. Dr. Klaz is a clinical informatician, dermatologist, and a former military surgeon.
He has specialized in the convergence of enterprise-level electronic health records, EHR interoperability, health care data science, clinical governance, patient outreach, risk, value-based care models, and provider engagement.
Dr. Klaz earned his doctor of medicine and bachelor of science degrees from the Hebrew University of Jerusalem, Israel and his master of healthcare informatics from the University of San Diego. He has served in various leadership positions as CMIO, SVP of Clinical Informatics, and Medical Director of HIT.
Karyn Wentz, MSN, RN, CPN
Nurse Informaticist
Wolters Kluwer
Karyn Wentz has 15 years of nursing experience in the areas of pediatrics, pediatric hematology and oncology, women's services, infection prevention and control, and informatics. She has worked in both teaching and community-based hospitals, which contributed to her deep understanding of clinical workflows. Karyn is passionate about the implementation of clinical decision support tools to improve health outcomes of patients. She earned a master of science in nursing informatics from Duke University. Karyn is a certified pediatric nurse through the Pediatric Nursing Certification Board (PNCB) and an active member of the Association for Professionals in Infection Control and Epidemiology (APIC).
-
Includes a Live Web Event on 06/23/2023 at 9:00 AM (PDT)
Half-day symposium featuring subject matter experts in precision medicine and sepsis.
Description:
Date: June 23, 2023
Time: 12:00 - 4:30 pm ET / 9:00 am - 1:30 pm PT
The clinical complexity and heterogeneity following infection and sepsis is a well-recognized challenge to effective patient management. Traditional pathogen-only targeted treatment currently remains the standard of care in diagnosis and treatment. Precision medicine, a concept that has been around for many years, applies host-directed diagnostics and therapeutics to use a person’s own genes or proteins as a potential way to yield more precise diagnoses, predict disease risk before symptoms occur, and design customized treatment plans that maximize safety and efficiency. For the medical community, precision medicine holds a lot of promise and hope for improved, personalized care and outcomes in infectious diseases and sepsis.
This Sepsis Alliance Symposium, focused on precision medicine in sepsis care and examining host-directed diagnosis and treatment for infectious diseases and sepsis, will allow learners to better understand the host response and how precision medicine might be applied. Presenters will also review host-based diagnostics across the continuum and explore the role of data and machine learning in host-based diagnostics and therapeutics.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Identify the immune activation to immune suppression;
- Review current host-directed diagnostics and phenotyping being researched, translated, and used in infection and sepsis care;
- List possible approaches to host-directed therapeutics in infection and sepsis care;
- Describe the role of data and machine learning in precision medicine.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Time (ET) Session Title Presenter 12:00-12:10 Welcome and Opening Remarks Steven Q. Simpson, MD 12:10-12:40 Session info coming soon Richard Hotchkiss, MD 12:40-1:10 Host Therapeutics for Pandemic Preparedness Kimberly Sciarretta, PhD 1:10-1:40 Shaping the Future of Sepsis Care: The Role of Phenotyping in Prognosis Azra Bihorac, MD, MS, FCCM, FASN 1:40-2:40 A Sepsis Innovation Collaborative (SIC) Roundtable: Challenges and Opportunities in Precision Sepsis Diagnosis Steven Q Simpson, MD
Tim Sweeney, MD, PhD
Debra M. Foster, BSc
Bobby Reddy Jr., PhD2:40-2:55 Break 2:55-3:25 Human Genomics of Infectious Diseases & Sepsis Samira Asgari, PhD 3:25-3:55 Session info coming soon 3:55-4:25 Resuscitation and Management: Knowns, Unknowns, and the Role for Big Data Andre L. Holder, MD, MS 4:25-4:30 Closing Remarks Steven Q Simpson, MD 
Steven Q. Simpson, MD (Moderator)
Professor of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine
University of Kansas
Steven Q. Simpson, MD is Professor of Medicine at the University of Kansas in the Division of Pulmonary, Critical Care, and Sleep Medicine, where he previously served as Division Director, Director of three ICUs, Chair of the Sepsis Team, and Chair of Multidisciplinary Critical Care. He has done research in all areas of severe sepsis from molecular and cellular mechanisms, to translational studies, to quality improvement studies.
He was a founder, in 2005, of the Midwest Critical Care Collaborative, a multidisciplinary and interprofessional collaborative effort to improve the quality of critical care services throughout the Midwest. In 2007, he initiated the Kansas Sepsis Project, a statewide program to improve severe sepsis care and outcomes throughout the state via continuing education both in sepsis and in quality improvement principles, and via inter-professional collaboration. He is currently heading a BCBS-sponsored sepsis collaborative among Kansas City metro area hospitals and is a contributing faculty member of the ongoing Surviving Sepsis Campaign collaboratives, leading the effort in the Midwest. He is a participant in the 2016 review and update of the Surviving Sepsis Campaign Guidelines.
Dr. Simpson was the North American co-chair of the International Single Day Point Prevalence Study for Severe Sepsis and Septic Shock (IMPRESS) in the fall of 2013. During his tenure at the University of New Mexico, he contributed to the discovery of a particular form of sepsis, the Hantavirus Pulmonary Syndrome, and published numerous papers on the clinical description, the hemodynamic description, and the approach to supportive care for patients with the syndrome, including extracorporeal hemodynamic and oxygenation support.
Dr. Simpson received his M.D. degree from the University of Kansas in 1983. He completed residency training in Internal Medicine at KU in 1986 and fellowship training in Pulmonary Diseases at Rush Medical College in 1989. He has been a faculty member at Rush Medical College, the University of New Mexico, and the University of Kansas. He is a regular reviewer for the journals Critical Care Medicine and CHEST, and he reviews on an ad hoc basis for Shock, the Journal of Intensive Care, JAMA, Virology, and Antiviral Therapy. He is the author of over 70 peer reviewed and invited manuscripts, book chapters, and web-based articles and presentations.
Dr. Simpson was the Third Eli Lilly and Company Distinguished Scholar in Critical Care Medicine, sponsored by the American College of Chest Physicians and the Chest Foundation for his work in reducing geographic disparities for severe sepsis care (the Kansas Sepsis Project). In 2013 he delivered the Roger C. Bone Memorial Lecture at the annual international meeting of the American College of Chest Physicians, describing the Kansas Sepsis Project. Dr. Bone was Dr. Simpson’s early career mentor and was the progenitor of the criteria used throughout the world to recognize severe sepsis.
No relevant financial relationships to disclose.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 3.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 3.0 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 05/17/2023
Learn how to recognize and address potential disparities in access to care, treatment, and outcomes for people in labor and delivery with sepsis.
Description:
Sepsis in labor and postpartum is a leading cause of maternal morbidity and mortality. In this special Maternal Sepsis Week program, you'll learn about the epidemiology of obstetric sepsis and how it affects different populations. Early detection and management of sepsis, awareness of inequities and recognizing the increased risk of adverse outcomes in some obstetrical patient populations is vital to improving outcomes.
The importance of equity considerations in sepsis care will also be explored, as well as how to recognize and address potential disparities in access to care, treatment, and outcomes for people in labor and delivery with sepsis.Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe the epidemiology of obstetric sepsis and inequities in sepsis care;
- Identify clinical and systems-based challenges in the early recognition and management of sepsis;
- Recognize potential strategies in identifying and treating patients with sepsis, with an eye on equity.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporter:
Sepsis Alliance gratefully acknowledges the support provided by the Ohio Hospital Association for this webinar.
Malavika Prabhu, MD
Maternal-Fetal Medicine (MFM) Specialist and Assistant Professor
Massachusetts General Hospital / Harvard Medical School
Malavika Prabhu, MD, is a maternal-fetal medicine (MFM) specialist and an assistant professor at Massachusetts General Hospital/Harvard Medical School in Boston, Massachusetts. Dr. Prabhu completed her obstetrics/gynecology residency at the University of Washington in Seattle, followed by her MFM fellowship at Massachusetts General Hospital. Her clinical interests include maternal sepsis, infectious diseases in obstetrics, and severe maternal mortality and morbidity.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.8 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 05/02/2023
Content provided by Seres Therapeutics / Aimmune Therapeutics (No CE credits offered)
Webinar Description:
In this webinar, the presenter will review diagnostic techniques and management strategies for patients with recurrent Clostridioides difficile infection (CDI) including the evolving use of live biotherapeutic products. It is critical that healthcare professionals are able to appropriately diagnose and manage recurrent CDI, as CDI, like any infection, can lead to sepsis and other complications.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Seres Therapeutics / Aimmune Therapeutics for this sponsored webinar.
Jessica R. Allegretti, MD, MPH, FACG
Medical Director, Crohn's and Colitis Center; Director, FMT Program
Brigham and Women's Hospital
Jessica Allegretti, MD, MPH, FACG, currently serves as the Medical Director of the Crohn’s and Colitis Center at the Brigham and Women’s Hospital. She developed and leads the hospital’s Fecal Microbiota Transplantation Program and is an international expert on the topic.
Maryann Webb
Recurrent C. Diff Survivor
Patient Advocate
Maryann Webb is a survivor of recurrent C. diff and will share her journey of how this common infection impacted her life and those of her family and friends. She will describe how she turned her difficult journey into advocacy for others affected with C. diff and for the development of new treatments for this infection.
-
Recorded On: 04/20/2023
Learn how to recognize patients with intellectual and developmental disabilities who are at increased risk of sepsis and develop a framework for evaluating patients with intellectual and developmental disabilities.
Description:
Having an intellectual disability puts many children at higher risk of sepsis. It is necessary to educate healthcare professionals about this heightened risk and the care needs of these children, to help prevent unnecessary complications and deaths from sepsis in this vulnerable population. During this webinar, attendees will learn how to recognize patients with intellectual and developmental disabilities who are at increased risk of sepsis, understand problems inherent in evaluating patients who cannot give a complete history, and develop a framework for evaluating patients with intellectual and developmental disabilities.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Recognize patients with intellectual and developmental disabilities who have an increased risk of sepsis;
- Describe the problems inherent in evaluating patients who cannot give a complete history;
- Develop a framework for evaluating patients with intellectual and developmental disabilities.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporter:
Sepsis Alliance gratefully acknowledges the Del E. Webb Foundation for their support of this webinar.
Garey Noritz, MD, FAAP, FACP
Chief, Division of Complex Health Care
Nationwide Children’s Hospital
Garey Noritz, MD, FAAP, FACP is an internist and pediatrician at Nationwide Children’s Hospital, and a professor of pediatrics at The Ohio State University. He is Chief of the Division of Complex Care, and serves as Chair of the Council on Children with Disabilities of the American Academy of Pediatrics.
Dr. Noritz graduated from Brown University School of Medicine. He completed his residencies in internal medicine and pediatrics at MetroHealth Medical Center/ Case Western Reserve University School of Medicine. He is Board Certified in internal medicine, pediatrics, neurodevelopmental disabilities, and hospice/ palliative medicine. He is also past Chair of the Lifespan Committee of the American Academy for Cerebral Palsy and Developmental Medicine.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.25 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 03/23/2023
Content provided by Beckman Coulter (No CE credits offered)
Webinar Description:
Rapid advancements in artificial intelligence (AI) in healthcare are significantly transforming the practice of medicine by enabling higher levels of efficiency and speed, care delivery, and confidence in decision making. During this presentation, participants will learn about emerging AI technology and its potential to revolutionize our approach to sepsis care by enabling rapid triaging and disposition of patients at risk for or suspected of having sepsis. AI-driven tools that support improved sepsis detection, diagnosis, and treatment will also be discussed. The presenter will review recently published scientific literature on this topic and provide a framework for understanding these tools and integrating them into clinical practice to achieve widespread adoption and deliver maximum impact.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Beckman Coulter for this sponsored webinar.
Jeremiah Hinson, MD, PhD
Associate Professor of Emergency Medicine, Associate Director of Research for the Department of Emergency Medicine
Johns Hopkins School of Medicine
Jeremiah Hinson, MD, PhD, is a clinician scientist who serves as an associate professor of emergency medicine and the Associate Director of Research for the Department of Emergency Medicine at Johns Hopkins School of Medicine. He is also faculty within the Malone Center for Engineering in Healthcare at Johns Hopkins and Co-Directs the Center for Data Science in Emergency Medicine, where he leads research on artificial intelligence (AI) and sepsis. His work includes the development and evaluation of AI-driven tools that facilitate individualized patient risk stratification and optimized resource allocation, evaluation of emerging sepsis biomarkers, and multicenter clinical trials to evaluate new approaches to sepsis therapy.
-
Recorded On: 03/09/2023
Learn about recognition and treatment of infections in ESKD, as well as the relationship between AKI and sepsis.
Description:
Studies have shown that death from sepsis in end-stage kidney disease (ESKD) patients can be up to 50% higher than that of the general population. Furthermore, acute kidney injury (AKI) is a frequent complication associated with sepsis, and AKI from sepsis carries an increased risk of morbidity and mortality.
During this special World Kidney Day webinar, presented by Sepsis Alliance, presenters will overview infections and sepsis risk factors, outcomes, hemodialysis access considerations, and treatments for ESKD patients. Participants will also learn about AKI risk factors from sepsis, and review treatments, outcomes, and post-sepsis and AKI recovery.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Review risk factors and outcomes of sepsis in ESKD;
- List hemodialysis access type and management considerations;
- Explain peritonitis and sepsis management in peritoneal dialysis patients;
- Discuss sepsis and AKI as concomitant risk factors;
- Describe sepsis and AKI treatments;
- Recall sepsis and AKI outcomes and recovery.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Clinical Community sponsors.
Leslie P. Wong MD, MBA, FACP, FASN
Senior Medical Director of Kidney Services and Nephrology; Chief Kidney Health Officer
Intermountain Healthcare
Leslie Wong, MD, MBA, FACP, FASN, is Intermountain Healthcare's Senior Medical Director of Kidney Services and Nephrology, and Chief Kidney Health Officer. In this capacity, Dr. Wong leads Intermountain’s efforts to deliver nationally recognized, valued-based care with an emphasis on reducing the incidence of kidney failure and improving the kidney health of communities across the Mountain West region of the United States.
Dr. Wong came to Intermountain from dual roles as Chief Medical Officer of Nephrology Care Alliance, a division of DaVita Inc., and Associate Medical Director of Cleveland Clinic's Medicare Accountable Care Organization. He is a seasoned nephrologist who has served as Cleveland Clinic's Vice-Chairman of Nephrology and Hypertension with an emphasis on clinical transformation, as the Director of the Center for Dialysis, and as an associate professor of medicine at Case Western Reserve University.
Dr. Wong is a graduate of the University of Texas Southwestern Medical School. He completed his residency and fellowship training at the University of North Carolina, where he was Chief Resident. He started his career in Seattle, where he was Medical Director of Peritoneal Dialysis at Northwest Kidney Centers. Following this work, he became Satellite Healthcare's Vice President of Clinical Affairs, leading quality and medical director education at that institution. He also served on the faculty at Stanford University.
Professionally, he is a nationally recognized nephrology educator and speaker. He is a past member of the American Society of Nephrology (ASN) Dialysis Advisory Group and Chair of Quality, Assessment, Improvement, and Education for Nephrologists Transforming Dialysis Safety (NTDS). Dr. Wong currently participates in the ASN Diabetic Kidney Collaborative and serves on the Excellence in Patient Care (EPC) Committee, helping to guide ASN’s clinical initiatives.
Anitha Vijayan, MD
Professor of Medicine Division of Nephrology; Medical Director, Acute Dialysis Services
Washington University in St. Louis; Barnes-Jewish Hospital
Anitha Vijayan, MD is professor of medicine in the Division of Nephrology, and the Medical Director of Acute Dialysis Services at Barnes-Jewish Hospital. She is a member of the American Society of Nephrology COVID-19 and Emerging Threats Response Team and the Chair of the AKINOW Recovery Sub-Committee. Her main area of clinical and research interest is improving outcomes in critically ill patients with AKI.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.6 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.25 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 03/07/2023
Content provided by BD (No CE credits offered)
Webinar Description:
Blood cultures are the gold standard test for sepsis diagnosis, and an essential first step in infectious organism identification. Improving blood culture quality is critical to the outcomes for a patient with suspected sepsis. Unfortunately, blood culture quality, including the test’s sensitivity and specificity, is notoriously susceptible to variances in the techniques and technologies used. This is concerning because compromised sensitivity decreases the likelihood of identifying an infection if it truly is present. If specificity is compromised, we run the risk of unnecessarily treating a falsely identified infection. Optimizing blood culture quality requires a team effort, starting with process improvement efforts at the patient’s bedside.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by BD for this sponsored webinar.
Janet S. Conner, MT(ASCP), CIC, MSPH
Infection Preventionist
Janet Conner has over 30 years of experience in infection control across a continuum of healthcare, including hospital, ambulatory care, long-term care, public health, home care, home medical equipment, chronic hemodialysis, and hospice. In her most recent role as the Regional Director, Infection Prevention of a large healthcare system, Janet was responsible for overseeing the Infection Prevention and Control programs of over 10 hospitals, including compliance with Joint Commission Infection Control Standards and national patient safety goals (NPSG) as well as promoting system-wide initiatives and campaigns to prevent hospital-acquired infections and improve patient care safety and quality.
Janet is a member of the Association for Practitioners in Infection Control and Epidemiology (APIC), Certification Board for Infection Control (CBIC), and Society for Healthcare Epidemiology of America (SHEA). She is also past president of the Mile High Chapter of APIC. She has been invited to speak at numerous regional events on topics including antimicrobial stewardships, infection prevention, and biosafety. Janet holds a Bachelor of Science in Microbiology/Medical Technology from Colorado State University and a Master of Public Health from Walden University.
-
Recorded On: 02/28/2023
Review several case studies highlighting the impact of sepsis on children with IDD and their families.
Description:
Children with intellectual and developmental disabilities (IDD) are at an increased risk of sepsis, making it imperative to educate healthcare professionals on their care needs and heightened vulnerability. This education is necessary to prevent avoidable complications and fatalities. In this presentation, participants will gain knowledge on trajectories of health-related quality of life and mortality among children with IDD, and review case studies that highlight the impact of sepsis on children with IDD and their families.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Review trajectories of health-related quality of life (HRQL) and mortality among children with community-acquired septic shock;
- Compare the healthcare needs of children with and without developmental disabilities;
- Review domains of HRQL after septic shock in children with developmental disabilities;
- Review the potential impact of pediatric septic shock on parents and families.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporter:
Sepsis Alliance gratefully acknowledges the Del E. Webb Foundation for their support of this webinar.
Kathleen Meert, MD, FCCM
Professor and Chair of the Dept. of Pediatrics
Central Michigan University
Kathleen Meert, MD, FACCM is Professor and Chair of the Department of Pediatrics at Central Michigan University, and Specialist-in-Chief at Children’s Hospital of Michigan. She is certified by the American Board of Pediatrics in General Pediatrics and Pediatric Critical Care Medicine. Dr. Meert is a clinical researcher with experience conducting single- and multi-site randomized trials and prospective observational studies in pediatric intensive care units (PICUs). She has been a Principal Investigator for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Collaborative Pediatric Critical Care Research Network since its inception in 2005, and has collaborated with several other national and international research networks. Dr. Meert serves on the NICHD National Advisory Committee for the Pediatric Critical Care and Trauma Scientist Development Program which aims to develop junior faculty as independent physician-scientists.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.5 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.25 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.